HERCULES, Calif., July 28, 2008 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the availability of two bulletins (numbers 5713 and 5692) describing a major study demonstrating how real-time quantitative PCR (rt-qPCR) analysis provides a convenient and reliable method for evaluating the knockdown efficiency and functional consequences of RNAi-mediated gene silencing. The study uses examples from neuroblastoma research conducted at Bio-Rad and by researchers at Ghent University, Belgium.
